Bing Zhu

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Pseudomonas Aeruginosa

Wastewater Treatment

Diffusion Weighted Imaging

Top Venues

Science advances

NPJ precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Peng Guo, Jing Huang, Bing Zhu, Andrew C Huang, Lingxiao Jiang, Jianmin Fang, Marsha A Moses
A rationally designed ICAM1 antibody drug conjugate eradicates late-stage and refractory triple-negative breast tumors in vivo. Science advances 9 (18) (2023)
Peng Guo, Jing Huang, Bing Zhu, Andrew C Huang, Lingxiao Jiang, Jianmin Fang, Marsha A Moses
A rationally designed ICAM1 antibody drug conjugate eradicates late-stage and refractory triple-negative breast tumors in vivo. Science advances 9 (18) (2023)
Peng Guo, Jing Huang, Bing Zhu, Andrew C Huang, Lingxiao Jiang, Jianmin Fang, Marsha A Moses
A rationally designed ICAM1 antibody drug conjugate eradicates late-stage and refractory triple-negative breast tumors in vivo. Science advances 9 (18) (2023)
Bing Zhu, Xinyan Wang, Takaya Shimura, Andrew C Huang, Nana Kong, Yujie Dai, Jianmin Fang, Peng Guo, Jie-Er Ying
Development of potent antibody drug conjugates against ICAM1 + cancer cells in preclinical models of cholangiocarcinoma. NPJ precision oncology 7 (1) (2023)
Peng Guo, Jing Huang, Bing Zhu, Andrew C Huang, Lingxiao Jiang, Jianmin Fang, Marsha A Moses
A rationally designed ICAM1 antibody drug conjugate eradicates late-stage and refractory triple-negative breast tumors in vivo. Science advances 9 (18) (2023)